More Than 700 Physicians and Administrators Participate in the Visian ICL Growth Program(... (er Wachler has made the Visian ICL an in...)

More Than 700 Physicians and Administrators Participate in the Visian ICL Growth Program(TM) Launch

Date:4/23/2008

er Wachler has made the Visian ICL an integral part of his successful practice, and we are delighted to have him share his story with other physicians. In future sessions of this nine part series other successful surgeons may be joining Dr. Boxer Wachler to share their experiences."

About STAAR Surgical

STAAR is a leader in the development, manufacture and marketing of minimally invasive ophthalmic products employing proprietary technologies. STAAR's products are used by ophthalmic surgeons and include the Visian ICL, a tiny, flexible lens implanted to correct refractive errors, as well as innovative products designed to improve patient outcomes for cataracts and glaucoma. Manufactured in Switzerland by STAAR, the ICL is approved by the FDA for use in treating myopia, has received CE Marking and is sold in more than 40 countries. More information is available at http://www.staar.com.

Safe Harbor

All statements in this press release that are not statements of historical fact are forward-looking statements, including any statements of the plans, strategies, and objectives of management for future operations, statements of belief and any statements of assumptions underlying any of the foregoing. These statements are based on expectations and assumptions as of the date of this press release and are subject to numerous risks and uncertainties, which could cause actual results to differ materially from those described in the forward-looking statements. The risks and uncertainties include our limited capital resources and limited access to financing, the challenge of managing foreign subsidiaries, the willingness of surgeons and patients to adopt a new product and procedure and other factors beyond our control, including those detailed from time to time in our reports filed with the Securities and Exchange Commission. STAAR assumes no obligation to update these forward-looking statements to reflec
'/>"/>

0

GOOD

Page: 1 2 3
Related biology technology :

1. Diageo Sponsors Medical Society of the State of New Yorks Physicians Training Program
2. Young Physicians Demanding Advanced Laparoscopic Energy Instruments
3. FDA Approves Additional Dosage Strengths of Shires ADHD Treatment VYVANSE(TM) (lisdexamfetamine dimesylate) Which May Help Physicians Tailor Treatment for Individual Patients
4. Physicians Practice, Loma Linda Partner to Improve Patient Care in Southern California
5. Physicians Reference Laboratory Announces New Diagnostic for Womens Health
6. Center for Molecular Medicine Partners with AviaraDx to Offer New Cancer Tests to Aid Physicians in Personalizing Treatment
7. Apieron, Inc. Announces FDA Clearance of the Insight(TM) eNO System to Assist Physicians with Patient Asthma Management
8. Hot Information for Physicians Treating Vasomotor Symptoms During the Menopausal Transition
9. Off-Label Stent Use: How Important Are FDA Approvals to Physicians?
10. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
11. Boston Scientific to Participate in the Bear Stearns 20th Annual Healthcare Conference

Post Your Comments:

More Than 700 Physicians and Administrators Participate in the Visian ICL Growth Program(...(er Wachler has made the Visian ICL an in...)